Direct-acting antivirals-based therapy decreases hepatic fibrosis serum biomarker microfibrillar-associated protein 4 in hepatitis C patients
Christian Mölleken, Maike Ahrens, Anders Schlosser, Julia Dietz, Martin Eisenacher, Helmut E. Meyer, Wolff Schmiegel, Uffe Holmskov, Christoph Sarrazin, Grith Lykke Sorensen, Barbara Sitek, Thilo Bracht
Clin Mol Hepatol. 2019;25(1):42-51. Published online 2018 Nov 19 DOI: https://doi.org/10.3350/cmh.2018.0029
Citations to this article as recorded by 
Role and new insights of microfibrillar‐associated protein 4 in fibrotic diseases
Long Zhu, Wenqun Gou, Lijia Ou, Binjie Liu, Manyi Liu, Hui Feng
APMIS.2024; 132(2): 55. CrossRef
Matrisome gene-based subclassification of patients with liver fibrosis identifies clinical and molecular heterogeneities
Wei Chen, Yameng Sun, Shuyan Chen, Xiaodong Ge, Wen Zhang, Ning Zhang, Xiaoning Wu, Zhuolun Song, Hui Han, Romain Desert, Xuzhen Yan, Aiting Yang, Sukanta Das, Dipti Athavale, Natalia Nieto, Hong You
Hepatology.2023; 78(4): 1118. CrossRef
Microfibrillar-associated protein 4 in health and disease
Reine Kanaan, Myrna Medlej-Hashim, Rania Jounblat, Bartosz Pilecki, Grith L. Sorensen
Matrix Biology.2022; 111: 1. CrossRef
Molecular structure and function of microfibrillar‐associated proteins in skeletal and metabolic disorders and cancers
Sipin Zhu, Lin Ye, Samuel Bennett, Huazi Xu, Dengwei He, Jiake Xu
Journal of Cellular Physiology.2021; 236(1): 41. CrossRef
Molecular Crosstalk between the Hepatitis C Virus and the Extracellular Matrix in Liver Fibrogenesis and Early Carcinogenesis
Emma Reungoat, Boyan Grigorov, Fabien Zoulim, Eve-Isabelle Pécheur
Cancers.2021; 13(9): 2270. CrossRef
Circadian, Week-to-Week, and Physical Exercise-Induced Variation of Serum Microfibrillar-Associated Protein 4
Susanne Gjørup Sækmose, René Holst, Tine Lottenburger, Henriette Ytting, Hans Jørgen Nielsen, Peter Junker, Anders Schlosser, Grith Lykke Sorensen
Biomarker Insights.2021; 16: 117727192110163. CrossRef
Pathological investigations and correlation research of microfibrillar-associated protein 4 and tropoelastin in oral submucous fibrosis
Binjie Liu, Wenqun Gou, Hui Feng
BMC Oral Health.2021;[Epub] CrossRef
The fibrotic response of primary liver spheroids recapitulates in vivo hepatic stellate cell activation
Inge Mannaerts, Nathalie Eysackers, Elise Anne van Os, Stefaan Verhulst, Tiffany Roosens, Ayla Smout, Andreas Hierlemann, Olivier Frey, Sofia Batista Leite, Leo A. van Grunsven
Biomaterials.2020; 261: 120335. CrossRef
Hepatocellular Carcinoma Risk According to Regimens for Eradication of Hepatitis C Virus; Interferon or Direct Acting Antivirals
Hye Won Lee, Dai Hoon Han, Hye Jung Shin, Jae Seung Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim
Cancers.2020; 12(11): 3414. CrossRef
Real-world single-center experience with direct-acting antivirals for improvement of the liver fibrosis after chronic hepatitis C treatment
Sun Hee Lee, Hyun Phil Shin, Joung Il Lee
Antiviral Chemistry and Chemotherapy.2020; 28: 204020662097483. CrossRef
Relationship between Microfibrillar-Associated Protein 4 Levels and Subclinical Myocardial Damage in Chronic Kidney Disease
Sonat Pınar Kara, Gülsüm Özkan, Demet Özkaramanlı Gür, Gaye Kübra Emeksiz, Ahsen Yılmaz, Nergiz Bayrakçı, Savaş Güzel
Cardiorenal Medicine.2020; 10(4): 257. CrossRef
Biomarker microfibril-associated glycoprotein 4 for non-invasive diagnosis and therapeutic evaluation of hepatic fibrosis in patients with hepatitis C
Young Woo Eom, Soon Koo Baik
Clinical and Molecular Hepatology.2019; 25(1): 37. CrossRef